US FDA Collects ‘Majority’ Of PDUFA Program Fees After Payment Plea

The revenue is expected to sustain the prescription drug user fee program moving forward after reserves were tapped at the start of fiscal year 2023.

bill payment
The FDA still used some user fee reserves to fund PDUFA operations even though many sponsors paid program fees on time. • Source: Shutterstock

US Food and Drug Administration officials avoided the prescription drug user fee financial crisis that threatened following its late September renewal.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from User Fees

More from Pathways & Standards